Data shows nearly 19% weight loss in people with overweight

Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)

Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , San Diego , California , United States , Boston , Massachusetts , Ingelheim , Rheinland Pfalz , Denmark , Ireland , Dublin , Copenhagen , Køavn , American , Irish , Carinne Brouillon , Anna Krassowska , Carel Le Roux , Eli Lilly , Zealand Pharma , David Kendall , Animal Health , Boehringer Ingelheim , Investor Relations Corporate Communications , Novo Nordisk , Professor At University College , Irish Life Health , World Health Organization , World Obesity Federation , World Heart Federation , American Diabetes Association , Johnson , Press Release , Zealand Pharma Phase , Diabetes Association , Scientific Sessions , University College , Principal Investigator , Human Pharma , Chief Medical Officer , Track Designation , Corporate Headquarters , Investor Relations , Dose Finding Study , Test Safety , Adults With Non Alcoholic Steatohepatitis , Zealand Pharma Receive , Investigational Treatment , World Obesity , Obes Rev ,